By Spondylitis Association of America
Sunday, August 25, 2019
“Today, the American College of Rheumatology (ACR), in partnership with the Spondylitis Association of America (SAA) and the Spondyloarthritis Research and Treatment Network (SPARTAN), released the 2019 Update of the Recommendations for the Treatment of Ankylosing Spondylitis (AS) and Nonradiographic Axial Spondyloarthritis (nr-axSpA).
The guidelines include 86 recommendations that provide updated and new guidance for the management of patients with AS and nr-axSpA in the areas of pharmacologic and non-pharmacologic treatment options; AS-related comorbidities; and disease activity assessment, imaging, and screening.”
These updated guidelines build on the original, 2015 treatment guidelines, which were the first treatment guidelines for US physicians for treating AS and nr-AxSpa, and included, “specific, actionable recommendations that clinicians could readily apply in their practices,” to better serve the patient.
Both the original and the 2019 update to the guidelines were developed as a partnership between the American College of Rheumatology (ACR), the Spondylitis Association of America (SAA) and the Spondyloarthritis Research & Treatment Network (SPARTAN).
These huge accomplishments wouldn’t have been possible without the generous support of SAA’s members and donors, as SAA provided the foundation funding for these undertakings, made certain that patients were active participants in the process, and has been closely involved in the projects. This is a big moment for our community and we are thrilled to see this project come to fruition.
Visit our careers page for available positions
16360 Roscoe Blvd. Ste. 100Van Nuys, CA 91406
(800) 777-8189 U.S. only
or (818) 892-1616*Please note: This is not a Crisis Hotline. If you are in a life-threatening crisis, please dial 911 for immediate help in the US. Please follow this link for crisis intervention resources.